{
    "Case ID": "087019",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent ownership and rights to sell"
    ],
    "Legal_Issue": [
        "Whether Novopharm is entitled to protection under s. 56 of the Patent Act for enalapril maleate purchased before patent issuance"
    ],
    "Governing_Law": [
        "Section 56 of the Patent Act"
    ],
    "Procedural_Stage": [
        "Application stage, court review"
    ],
    "Evidence_Assessment": [
        "Delmar's certificate of analysis indicating product met specifications"
    ],
    "Decision_Outcome": [
        "Novopharm is entitled to protection under s. 56; application dismissed"
    ],
    "Burden_of_Proof": [
        "On Merck to prove infringement"
    ],
    "Credibility_Factor": [
        "Deliverability of the product on October 1, 1990, as indicated by certificate of analysis"
    ],
    "Legal_Rule": [
        "Section 56 allows use and sale of invention if purchased or acquired before patent application becomes public"
    ],
    "Standard_of_Review": [
        "Statutory interpretation and factual assessment"
    ],
    "Procedural_Issue": [
        "Timing of purchase relative to patent issuance"
    ],
    "Grounds_for_Claim": [
        "Merck claimed Novopharm infringed its patent by selling enalapril maleate"
    ],
    "Outcome_on_Merits": [
        "In favor of Novopharm"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed"
    ],
    "Review_Standard": [
        "Interpretation of statutory provisions and evaluation of transaction timing"
    ],
    "Procedural_Fairness_Assessment": [
        "Fair opportunity to present evidence on timing and deliverability"
    ],
    "Key_Evidence_Considered": [
        "Date of receipt (October 1, 1990), certificate of analysis"
    ],
    "Legal_Framework": [
        "Canadian Patent Act"
    ],
    "Applicant_Challenge": [
        "Merck sought to prohibit Novopharm from selling the product"
    ],
    "Court_Result": [
        "Dismissed Merck's application"
    ],
    "Legal_Rule_Source": [
        "Patent Act, R.S.C. 1985, c. P-4"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Asserted protection under s. 56 due to pre-patent purchase"
    ],
    "Evidence_Type": [
        "Documentary evidence (certificate of analysis)"
    ],
    "Remedy_Requested": [
        "Injunction to prevent sale by Novopharm"
    ],
    "Outcome": [
        "No infringement; Novopharm may sell the product"
    ],
    "Decision_Authority": [
        "Trial Court"
    ],
    "Remedy_Sought": [
        "Prohibition of sale"
    ],
    "Resolution_Mechanism": [
        "Judicial determination"
    ],
    "Legal_Provision": [
        "Section 56 of the Patent Act"
    ],
    "Authority": [
        "Patent Act"
    ],
    "Claimant_Status": [
        "Patent holder (Merck)"
    ],
    "Legal_Provision_Cited": [
        "s. 56, Patent Act"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of patent infringement"
    ],
    "Applicable_Process": [
        "Civil litigation"
    ],
    "Outcome_of_Review": [
        "Merck's claim rejected"
    ],
    "Pending_Relief_or_Application": [
        "Application for injunction"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Section 56 of the Patent Act"
    ]
}